Search

You searched for "retinal"

3324 results found

EDTA chelation for band keratopathy

1 June 2018 | | EYE - Cornea, EYE - General
The authors describe a retrospective analysis of 89 eyes from 72 patients who underwent ethlenediamine tetra-acetic acid (EDTA) chelation for band keratopathy. The ratio of R:L eye was 41:48. The mean age was 71 years (range 18-93 years). Thirty-two out...

Bleomycin for conjunctival lymphangioma

3 April 2023 | | EYE - Oculoplastic, EYE - Orbit
This is a retrospective review of 16 eyes which underwent intralesional / sub-conjunctival injections of bleomycin sclerotherapy for conjunctival lymphatic malformations (lymphangiomas). The mean age was 18 (range three to 59 years). Four of the lesions were microcystic and 12...

Topcon Healthcare National OCT Conference (prior to Optix Conference)

12 March 2023 -13 March 2023
by Laura Williams The National Optical Coherence Tomography (OCT) Conference – the industry conference organised by Topcon Healthcare – went ahead as an in-person event for the first time in three years. It was a widely welcomed return to in-person...

Birmingham Optical Achieves UKAS ISO 9001 Certification

5 August 2025 | Company Profiles, Awards, Conferences & Anniversaries
Birmingham Optical, a leading UK provider of optical equipment and services, has been awarded the prestigious UKAS ISO 9001 certification, a globally recognised standard for quality management systems (QMS). This milestone reflects the company’s dedication to excellence, consistency, and customer...

Landmark review of glaucoma treatment and research published by Moorfields-led team

22 September 2023 | moorfields, glaucoma, research, developments, guzzard, the eagle, MIGS, Omni
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.

Moorfields- Botulinum toxin: Is it injector error, side effects or complications July

7 July 2025
This course is designed to improve clinical practice and improve the treatment, management and administration of botulinum toxin for blepharospasm, hemifacial spasm, bells palsy, gustatory lacrimation and entropion. OverviewDeveloped by Moorfields Adnexal Nurse Consultant Nicola Dunlop and delivered in conjunction...

Foundation Post in Ophthalmology

7 February 2023 | | EYE - General
If you are in your final year of medicine at university, firstly congratulations on making it so far and secondly, you may be wondering how and which jobs to rank highly. If you have found yourself reading this article, then...

RCOphth Annual Congress 2022 - Preview

19 May 2022
Eye News previews the RCOphth Annual Congress 2022, as we look forward to the return of an in-person Congress for the first time since 2019. Follow updates and key events here.

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

1 August 2018 | | EYE - Cornea, EYE - General
The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...

Applying for ophthalmology ST1 in 2026: What’s new?

5 December 2025 | | EYE - General
Competition for ophthalmology ST1 has intensified steadily over recent cycles, rising from ~9:1 (2022) to ~10:1 (2023), ~14:1 (2024) and ~22:1 (2025) [1]. Against this background, applicants benefit from a structured approach: mapping achievements to portfolio domains early, identifying gaps...

SightCare Conference 2023

29 January 2023 -30 January 2023
The SightCare conference brings independent optical practice’s together on 29 and 30 January 2023 at the Telford International Centre to network with their colleagues and peers and enjoy two days of workshops, keynote speakers, CPD education, learning and fun. This...

The results of the last survey Oct22

3 October 2022 | | EYE - General
I thank everyone for their time in responding to this edition’s survey questions. The first question relates to an issue I have previously discussed around consent for second eye cataract surgery. I touch on this point again for two reasons....